Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biocryst Pharmaceuticals

Clinical trials sponsored by Biocryst Pharmaceuticals, explained in plain language.

BioCryst Pharmaceuticals BCRX NASDAQ

A biopharmaceutical company developing oral therapies for rare diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 4 Completed 1 Terminated 2

New drug trial hopes to tame rare skin disease

Disease control Recruiting now

This early-stage trial tests a new drug called BCX17725 in healthy volunteers and people with Netherton syndrome, a rare genetic skin condition. The study aims to check safety, how the drug moves through the body, and whether it can reduce skin redness and scaling. About 78 parti…

Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC